The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to ...

As global markets experience a rebound, driven by easing core U.S. inflation and strong bank earnings, investors are increasingly optimistic about potential rate cuts later in the year. This positive ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Continued pricing pressures from governments and patient groups are driving small molecule CDMOs to focus on reducing the ...

Pharma Sector Multibagger Opportunity - Explore how India could win big in the CDMO space with China-Plus-One strategy, ...

Strides Pharma share price has fallen over 10% in one month and 16% in three months. However, Strides Pharma stock has ...

Hepion Pharmaceuticals has had a turbulent year so far. With a YTD performance of -68.60%, its stock has struggled to gain traction in the market. This starkly contrasts with the broader market, as ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...